ZIMV icon

ZimVie

18.87 USD
-0.01
0.05%
At close Updated Sep 12, 4:00 PM EDT
Pre-market
After hours
18.87
0.00
0%
1 day
-0.05%
5 days
-0.05%
1 month
0.11%
3 months
103.34%
6 months
49.17%
Year to date
36.44%
1 year
16.19%
5 years
-26.09%
10 years
-26.09%
 

About: ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

Employees: 1,770

0
Funds holding %
of 7,462 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

11,450% more call options, than puts

Call options by funds: $231K | Put options by funds: $2K

48% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 42

3.64% more ownership

Funds ownership: 83.18% [Q1] → 86.82% (+3.64%) [Q2]

5% less funds holding

Funds holding: 256 [Q1] → 244 (-12) [Q2]

9% less capital invested

Capital invested by funds: $249M [Q1] → $226M (-$22.6M) [Q2]

18% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 33

100% less funds holding in top 10

Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$19
1% upside
Avg. target
$19
1% upside
High target
$19
1% upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Barclays
Matt Miksic
$19
Equal-Weight
Upgraded
22 Jul 2025

Financial journalist opinion

Neutral
GlobeNewsWire
20 days ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZIMV and CIO on Behalf of Shareholders
NEW YORK, Aug. 23, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZIMV and CIO on Behalf of Shareholders
Neutral
The Motley Fool
1 month ago
ZimVie (ZIMV) Q2 EPS Doubles to $0.26
ZimVie (ZIMV) Q2 EPS Doubles to $0.26
ZimVie (ZIMV) Q2 EPS Doubles to $0.26
Neutral
GlobeNewsWire
1 month ago
ZimVie Reports Second Quarter 2025 Financial Results
Recently entered into definitive agreement to be acquired by ARCHIMED for $19.00 in cash per share Net Sales from Continuing Operations of $116.7 million Net Loss from Continuing Operations of $(3.8) million; Net Loss margin of (3.3)% Adjusted EBITDA [1] from Continuing Operations of $17.5 million; Adjusted EBITDA [1] margin of 15.0% GAAP diluted EPS from Continuing Operations of $(0.14) and adjusted diluted EPS [1] from Continuing Operations of $0.26 PALM BEACH GARDENS, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today reported financial results for the quarter ended June 30, 2025.
ZimVie Reports Second Quarter 2025 Financial Results
Neutral
GlobeNewsWire
1 month ago
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025
PALM BEACH GARDENS, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter 2025 and file its Quarterly Report on Form 10-Q after market close on Wednesday, July 30, 2025.
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025
Neutral
GlobeNewsWire
1 month ago
ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China
PALM BEACH GARDENS, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced a strategic distribution agreement with Osstem Implant Co., Ltd.
ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China
Neutral
Business Wire
1 month ago
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ZimVie Inc. (NasdaqGS: ZIMV) to an affiliate of ARCHIMED. Under the terms of the proposed transaction, shareholders of ZimVie will receive $19.00 in cash for each share of ZimVie that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, o.
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV
Neutral
GlobeNewsWire
1 month ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders
Neutral
GlobeNewsWire
1 month ago
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ZimVie Inc. (NASDAQ: ZIMV)
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating ZimVie Inc. (NASDAQ: ZIMV ) related to its sale to an affiliate of ARCHIMED. Under the terms of the proposed transaction, ZimVie shareholders will receive $19.00 in cash per share. Is it a fair deal?
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ZimVie Inc. (NASDAQ: ZIMV)
Neutral
Investors Business Daily
1 month ago
ZimVie Doubles — And Then Some — On Its Second Takeover Deal
ZimVie shares catapulted by triple digits Monday after the dental implant maker agreed to a $730 million takeover deal.
ZimVie Doubles — And Then Some — On Its Second Takeover Deal
Neutral
PRNewsWire
1 month ago
Shareholder Alert: The Ademi Firm investigates whether ZimVie Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE , July 21, 2025 /PRNewswire/ -- The Ademi Firm is investigating ZimVie (NASDAQ: ZIMV) for possible breaches of fiduciary duty and other violations of law in its transaction with ARCHIMED. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
Shareholder Alert: The Ademi Firm investigates whether ZimVie Inc. is obtaining a Fair Price for its Public Shareholders
Charts implemented using Lightweight Charts™